Holen Sie sich die Stockscreener-App
23.93
3.48%
0.805
Schlusskurs vom Vortag:
$23.12
Offen:
$23.36
24-Stunden-Volumen:
14,114
Relative Volume:
0.25
Marktkapitalisierung:
$223.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-8.68%
1M Leistung:
+9.50%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$22.40
$24.89
1-Wochen-Bereich:
$22.40
$27.76
52-Wochen-Spanne:
$15.80
$34.31
Tvardi Therapeutics Inc Stock (TVRD) Company Profile
Firmenname
Tvardi Therapeutics Inc
Sektor
Branche
Telefon
(713) 489-8654
Adresse
3 SUGAR CREEK CTR. BLVD., SUGAR LAND
Vergleichen Sie TVRD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TVRD
Tvardi Therapeutics Inc
|
23.93 | 225.97M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tvardi Therapeutics Inc Stock (TVRD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-14 | Eingeleitet | Raymond James | Outperform |
| 2025-07-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-21 | Eingeleitet | Oppenheimer | Outperform |
| 2025-05-15 | Eingeleitet | BTIG Research | Buy |
| 2024-06-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-06-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-06-13 | Herabstufung | Needham | Buy → Hold |
| 2024-06-13 | Herabstufung | Stifel | Buy → Hold |
| 2023-03-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-11-01 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-08-03 | Eingeleitet | JP Morgan | Neutral |
| 2020-04-21 | Bestätigt | H.C. Wainwright | Buy |
| 2019-08-12 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-29 | Bestätigt | Laidlaw | Buy |
| 2019-02-06 | Fortgesetzt | Jefferies | Buy |
| 2019-01-15 | Eingeleitet | BofA/Merrill | Neutral |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Eingeleitet | Jefferies | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2018-06-28 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-12 | Fortgesetzt | H.C. Wainwright | Buy |
| 2018-02-12 | Hochstufung | Janney | Neutral → Buy |
| 2018-01-19 | Eingeleitet | Seaport Global Securities | Buy |
Alle ansehen
Tvardi Therapeutics Inc Aktie (TVRD) Neueste Nachrichten
Can volume confirm reversal in Tvardi Therapeutics Inc.Buy/Sell Zone Confirmation Technical Analysis - Newser
Is Tvardi Therapeutics Inc. trending in predictive chart modelsForecasting Stock Moves with AI Insights - Newser
Is this a good reentry point in Tvardi Therapeutics Inc.Secure Buy Strategy Based on Risk Parameters - Newser
Top chart patterns to watch in Tvardi Therapeutics Inc.Real Time Trade Execution Alert Plan - Newser
How sentiment analysis helps forecast Tvardi Therapeutics Inc.Free Value Investing Picks With Stability - Newser
Will Tvardi Therapeutics Inc. stock go up soonFree Trend Following Strategy With Stop Loss - Newser
What high frequency data says about Tvardi Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser
Analyzing Tvardi Therapeutics Inc. with risk reward ratio chartsFree Alpha Driven Watchlist With Alerts - Newser
Volatility clustering patterns for Tvardi Therapeutics Inc.Historical Volatility and Pattern Breakdown Analysis - Newser
What machine learning models say about Tvardi Therapeutics Inc.Early Entry Planner for Swing Candidates - Newser
Building trade automation scripts for Tvardi Therapeutics Inc.Top Stock Picks with Forecast Accuracy - Newser
Is Tvardi Therapeutics Inc. meeting your algorithmic filter criteriaFree High Accuracy Alerts for ROI Traders - Newser
Can technical indicators confirm Tvardi Therapeutics Inc.’s reversalFree Technical Entry Strategy for Beginners - Newser
Published on: 2025-08-04 07:15:03 - metal.it
Does Tvardi Therapeutics Inc. stock perform well during market downturnsUnprecedented profits - Jammu Links News
Should I hold or sell Tvardi Therapeutics Inc. stock in 2025Build a winning investment portfolio - Jammu Links News
Tvardi Therapeutics Inc. Stock Analysis and ForecastGet alerts on high-potential market moves - Jammu Links News
How volatile is Tvardi Therapeutics Inc. stock compared to the marketGet high-impact stock recommendations now - Jammu Links News
Is Tvardi Therapeutics Inc. a good long term investmentInvest confidently with real-time updates - Jammu Links News
What is the risk reward ratio of investing in Tvardi Therapeutics Inc. stockRealize exceptional returns through smart trading - Jammu Links News
How institutional ownership impacts Tvardi Therapeutics Inc. stockDownside Control Plan With Support Analysis - Newser
How does Tvardi Therapeutics Inc. generate profit in a changing economyRapid wealth multiplication - Jammu Links News
What are analysts’ price targets for Tvardi Therapeutics Inc. in the next 12 monthsCapitalize on market momentum for maximum gains - Jammu Links News
What institutional investors are buying Tvardi Therapeutics Inc. stockBuild wealth steadily with smart stock selection - Jammu Links News
What catalysts could drive Tvardi Therapeutics Inc. stock higher in 2025Build wealth steadily with smart stock selection - Jammu Links News
What recovery options are there for Tvardi Therapeutics Inc.Watchlist Summary for Active Day Traders - Newser
Is Tvardi Therapeutics Inc. stock poised for growthDaily Market Momentum and Pressure Analysis - Newser
How to build a custom watchlist for Tvardi Therapeutics Inc.Free Risk Controlled Picks With Real Returns - Newser
Published on: 2025-07-31 10:29:26 - metal.it
Finanzdaten der Tvardi Therapeutics Inc-Aktie (TVRD)
Es liegen keine Finanzdaten für Tvardi Therapeutics Inc (TVRD) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):